Drug intelligence / Profile preview

(Rp,Rp)-10

Development stage
Preclinical
Lead developer
Nankai University Business School
Modality
Small Molecules
Administration
Intravenous
01

Overview

(Rp,Rp)-10 is a stereopure, alkyne-conjugated, esterase-sensitive prodrug of the deoxyribose cyclic dinucleotide (dCDN) 3',3'-c-di-dAMP. It acts as a potent agonist of the Stimulator of Interferon Genes (STING) pathway. By utilizing a phosphotriester modification with specific (Rp,Rp) chirality, the molecule exhibits enhanced cellular permeability and stability compared to its parent CDN. Upon enzymatic cleavage by intracellular esterases, it releases the active CDN, leading to robust activation of the TBK1/IRF3 signaling axis and subsequent production of Type I interferons (e.g., IFN-β). In preclinical models of colon carcinoma, (Rp,Rp)-10 has demonstrated superior antitumor efficacy, achieving high rates of complete tumor regression and inducing long-term immunological memory.

Other names
(Rp,Rp)-isomer of alkyne-conjugated dCDN prodrug 10(Rp,Rp)-phosphotriester dCDN prodrug
02

Targets

STING (Stimulator of interferon genes protein)

Beyond the preview

Go deeper on (Rp,Rp)-10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (Rp,Rp)-10.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call